11.04.2011 • News

Merck, Sun Pharma Eye India Marketing Tie-Up

U.S. drugmaker Merck & Co is close to striking a marketing alliance with Sun Pharmaceutical Industries for the Indian market, the Mint reported on Monday.

The partnership between Sun and MSD Pharmaceuticals, the Indian arm of the U.S. drugmaker, could either be a marketing joint venture or a co-marketing tie-up, the newspaper said citing sources it did not name.

An announcement was likely on Monday, it said, adding officials at both the companies declined comment.

In January, German drugmaker Bayer signed an agreement with India's Cadila Healthcare to set up a joint venture to market products locally.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.